Who owns BioCryst Pharmaceuticals?

Key details on BioCryst Pharmaceuticals (Ticker: BCRX)

Who owns BioCryst Pharmaceuticals?

Is BCRX a good stock to own? Find out who bought BioCryst Pharmaceuticals, who sold BioCryst Pharmaceuticals (BCRX) stock, and who holds a large position in BioCryst Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Baker Bros. Advisors 14.11M $160.86M Sept. 30, 2015
Vanguard 9.38M $106.60M Sept. 30, 2015
FMR 7.75M $88.35M Sept. 30, 2015
Wellington Management Company 7.50M $85.52M Sept. 30, 2015
STATE STREET CORPORATION 3.15M $35.94M Sept. 30, 2015
BlackRock Fund Advisors 2.91M $33.19M Sept. 30, 2015
D. E. Shaw & Co 2.47M $28.19M Sept. 30, 2015
RTW INVESTMENTS 2.20M $25.05M Sept. 30, 2015
SUSQUEHANNA INTERNATIONAL 1.74M $18.46M March 31, 2014
VHCP Management 1.74M $15.75M March 31, 2015
BlackRock Institutional Trust Company, N.A. 1.69M $19.29M Sept. 30, 2015
Franklin Resources 1.41M $16.11M Sept. 30, 2015
QVT Financial 1.36M $15.48M Sept. 30, 2015
Jennison Associates 1.32M $15.10M Sept. 30, 2015
Technical Financial Services 1.21M $8.84M Sept. 30, 2013
Inves 1.20M $13.67M Sept. 30, 2015
RA Capital Management 1.20M $13.64M Sept. 30, 2015
TPG Group Holdings 1.16M $12.30M March 31, 2014
TPG Capital 1.16M $3.21M Sept. 30, 2011
T. Rowe Price Associates 1.11M $12.62M Sept. 30, 2015
Cormorant Asset Management 1.08M $12.31M Sept. 30, 2015
GOLDMAN SACHS 1.05M $12.02M Sept. 30, 2015
Millennium Management 954888 $10.89M Sept. 30, 2015
Deerfield Management Company 907920 $9.61M March 31, 2014
NORTHERN TRUST 899132 $10.26M Sept. 30, 2015

Who sold BioCryst Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
BAM Capital Dec. 31, 2010 861485 $4.45M